Buffalo-based Garwood Medical Devices develops electrical-stimulation technology for bacterial biofilm infections on implanted medical devices. In partnership with the University at Buffalo, the company has built its BioPrax™ platform around low-voltage electrochemical disruption, with the device currently under investigation and granted FDA Breakthrough Device designation in 2019. The company was named for two veterans in the family of President and CEO Wayne D. Bacon and holds multiple patents on its platform technology.
FDA Breakthrough Device Designation
Compliance program
BioElectronics CorporationFounded by Andrew J. Whelan in 2000, Frederick-based BioElectronics Corporation develops and manufactures wearable, drug-free electroceutical devices that use pulsed shortwave therapy for pain management. The company operates as an OEM and works with commercial and international partners to bring its ActiPatch and RecoveryRx devices to consumer and clinical markets, with four FDA 510(k) clearances and published randomized clinical research supporting its technology.JEFFERSON, MD
Rookery LabsRookery Labs operates a Western New York innovation incubator for medical-device research, development, and engineering. Based in Buffalo, the company brings researchers, engineers, and healthcare professionals together while developing medical-technology talent and supporting healthcare ventures. Its quality system is certified to ISO 13485.BUFFALO, NY
ReBuilder Medical, IncReBuilder Medical develops the ReBuilder®, a prescription, FDA-cleared electrical stimulation device for at-home management of neuropathy and other chronic pain. Inventor and founder David B. Phillips created the original system for his father more than 30 years ago, and the company has continued producing and updating it since 1988. Based in Charles Town, West Virginia, ReBuilder Medical also supports physicians and veterans using the device in clinical and home-care settings.CHARLES TOWN, WV
Galvani BioelectronicsGalvani Bioelectronics is a clinical-stage company developing bioelectronic medicines through implant-based direct modulation of specific neural signals to organs central in chronic disease. The company's lead therapy targets Rheumatoid Arthritis via splenic nerve stimulation using a minimally invasive, laparoscopically implanted neuromodulation platform.UPPER PROVIDENCE, PA